1 |
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.  |
미소장 |
2 |
Anderson GL, Limacher M, Assaf AR, et al.: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA 2004;291:1701–1712. |
미소장 |
3 |
Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D: Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995;85:304–313. |
미소장 |
4 |
Low-dose estrogen therapy for prevention of osteoporosis: working our way back to monotherapy.  |
미소장 |
5 |
Effects of Ultralow-Dose Transdermal Estradiol on Bone Mineral Density: A Randomized Clinical Trial  |
미소장 |
6 |
Ettinger B: Rationale for use of lower estrogen doses for postmenopausal hormone therapy. Maturitas 2007;57:81–84. |
미소장 |
7 |
Samsioe G, Dvorak V, Genazzani AR, et al.: One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women. Maturitas 2007;57:171–181. |
미소장 |
8 |
Similar efficacy of low and standard doses of transdermal estradiol in controlling bone turnover in postmenopausal women.  |
미소장 |
9 |
Type and route of estrogen administration.  |
미소장 |
10 |
Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers.  |
미소장 |
11 |
Grady D: Clinical practice. Management of menopausal symptoms. N Engl J Med 2006;355:2338–2347. |
미소장 |
12 |
Botanical dietary supplement use in peri- and postmenopausal women.  |
미소장 |
13 |
Singh SR, Levine MA: Natural health product use in Canada: analysis of the National Population Health Survey. Can J Clin Pharmacol 2006;13:e240–e250. |
미소장 |
14 |
Sacco SM, Jiang JM, Reza-López S, Ma DW, Thompson LU, Ward WE: Flaxseed does not antagonize the effect of ultra-lowdose estrogen therapy on bone mineral density and biomechanical bone strength in ovariectomized rats. J Environ Health Toxicol A 2009;72:1209–1216. |
미소장 |
15 |
Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats.  |
미소장 |
16 |
Chen J, Saggar JK, Corey P, Thompson LU: Flaxseed and pure secoisolariciresinol diglucoside, but not flaxseed hull, reduce human breast tumor growth (MCF-7) in athymic mice. J Nutr 2009;139:2061–2066. |
미소장 |
17 |
Dietary Phytoestrogen Intake—Lignans and Isoflavones—and Breast Cancer Risk (Canada)  |
미소장 |
18 |
Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer  |
미소장 |
19 |
Mammalian lignan production from various foods  |
미소장 |
20 |
Wang LQ, Meselhy MR, Li Y, Qin GW, Hattori M: Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone. Chem Pharm Bull (Tokyo) 2000;48:1606–1610. |
미소장 |
21 |
Origin of lignans in mammals and identification of a precursor from plants.  |
미소장 |
22 |
Production and metabolism of lignans by the human faecal flora.  |
미소장 |
23 |
Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator.  |
미소장 |
24 |
Enterolactone inhibits the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in the rat.  |
미소장 |
25 |
Bergman Jungestrom M, Thompson LU, Dabrosin C: Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin Cancer Res 2007;13:1061–1067. |
미소장 |
26 |
Penttinen-Damdimopoulou PE, Power KA, Hurmerinta TT, Nurmi T, van der Saag PT, Makela SI: Dietary sources of lignans and isoflavones modulate responses to estradiol in estrogen reporter mice. Mol Nutr Food Res 2009;53:996–1006. |
미소장 |
27 |
Consumption of a flaxseed-rich food is not more effective than a placebo in alleviating the climacteric symptoms of postmenopausal women.  |
미소장 |
28 |
Power KA, Ward WE, Chen JM, Saarinen NM, Thompson LU: Flaxseed and soy protein isolate, alone and in combination, differ in their effect on bone mass, biomechanical strength, and uterus in ovariectomized nude mice with MCF-7 human breast tumor xenografts. J Toxicol Environ Health A 2007;70:1888–1896. |
미소장 |
29 |
Dietary Flaxseed Enhances the Inhibitory Effect of Tamoxifen on the Growth of Estrogen-Dependent Human Breast Cancer (MCF-7) in Nude Mice  |
미소장 |
30 |
Canadian Council on Animal Care: Guide to the Care and Use of Experimental Animals, Vol. 1. Canadian Council on Animal Care, Ottawa, Canada, 1993. |
미소장 |
31 |
Reeves PG, Nielsen FH, Fahey GC Jr: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of the AIN-76A Rodent Diet. J Nutr 1993;123:1939–1951. |
미소장 |
32 |
North American Menopause Society: Hormone products for postmenopausal use in the United States and Canada. 2010. www.menopause.org/htcharts.pdf (accessed April 16, 2011). |
미소장 |
33 |
Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH: Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. JAMA 2002;287:2668–2676. |
미소장 |
34 |
P53 and PCNA immunoexpression in endometrial carcinomas.  |
미소장 |